Literature DB >> 25503099

Corrigendum to "The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons" [FEBS Open Bio 4 (2014) 1-10].

Daiyu Honda1, Shinsuke Ishigaki1, Yohei Iguchi1, Yusuke Fujioka1, Tsuyoshi Udagawa1, Akio Masuda2, Kinji Ohno2, Masahisa Katsuno1, Gen Sobue1.   

Abstract

[This corrects the article DOI: 10.1016/j.fob.2013.11.001.].

Entities:  

Year:  2014        PMID: 25503099      PMCID: PMC4261070          DOI: 10.1016/j.fob.2014.11.007

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.693


The authors regret that the wrong sequences were given for two of the shRNAs. The sequence of shTDP2 should be AAGCAAAGATGTCTGAATA and the sequence of shCont should be AATTCTCCGAACGTGTCACGT. The corrected paragraph is given below, with the altered text underlined:

Lentivirus

We designed two different shRNAs against mouse Tardbp (Tdp-43), Fus, and a control shRNA. The targeted sequences were 5′-CGATGAACCCATTGAAATA-3′ for shRNA/TDP-43-1 (shTDP1); 5′-AAGCAAAGATGTCTGAATA-3′ for shRNA/TDP-43-2 (shTDP2); 5′-GCAACAAAGCTACGGACAA-3′ for shRNA/FUS1 (shFUS1); 5′-GAGTGGAGGTTATGGTCAA-3′ for shRNA/FUS2 (shFUS2); 5′-GGCTTAAAGTGCAGCTCAA-3′ for shRNA/Cugbp1 (shCugbp1); and 5′-AATTCTCCGAACGTGTCACGT-3′ for shRNA/control (shCont). The shRNAs were cloned into a lentiviral shRNA vector (pLenti-RNAi-X2 puro DEST, w16-1, which was a kind gift from Dr. Eric Campeau at Resverlogix Corp.). Lentivirus was prepared in accordance with the protocols detailed by Campeau et al. [25]. The authors apologize for any inconvenience caused and are pleased to have the opportunity to make this correction.
  5 in total

Review 1.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

Review 2.  Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS.

Authors:  Kazuhide Asakawa; Hiroshi Handa; Koichi Kawakami
Journal:  Cell Mol Life Sci       Date:  2021-03-11       Impact factor: 9.261

Review 3.  Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art.

Authors:  Matthew J Walsh; Johnathan Cooper-Knock; Jennifer E Dodd; Matthew J Stopford; Simeon R Mihaylov; Janine Kirby; Pamela J Shaw; Guillaume M Hautbergue
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

4.  The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing.

Authors:  Y Mao; T Tamura; Y Yuki; D Abe; Y Tamada; S Imoto; H Tanaka; H Homma; K Tagawa; S Miyano; H Okazawa
Journal:  Cell Death Dis       Date:  2016-04-28       Impact factor: 8.469

5.  ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.

Authors:  Jone López-Erauskin; Takahiro Tadokoro; Michael W Baughn; Brian Myers; Melissa McAlonis-Downes; Carlos Chillon-Marinas; Joshua N Asiaban; Jonathan Artates; Anh T Bui; Anne P Vetto; Sandra K Lee; Ai Vy Le; Ying Sun; Mélanie Jambeau; Jihane Boubaker; Deborah Swing; Jinsong Qiu; Geoffrey G Hicks; Zhengyu Ouyang; Xiang-Dong Fu; Lino Tessarollo; Shuo-Chien Ling; Philippe A Parone; Christopher E Shaw; Martin Marsala; Clotilde Lagier-Tourenne; Don W Cleveland; Sandrine Da Cruz
Journal:  Neuron       Date:  2018-10-18       Impact factor: 17.173

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.